Jiahong Dental 2025 Annual Report: Revenue of RMB 511 Million, Implant Product Revenue Down 16.71% Year-on-Year

Source: Jiahong Dental 2025 Annual Report

Revenue of RMB 511 Million Down 1.31% YoY / Net Profit Attributable to Shareholders of the Parent Company Down 11.26% / Investing in Overseas Subsidiaries to Cope with Tariff Fluctuations

DentalGoodNews｜On April 28, 2026, Shenzhen Jiahong Dental Co., Ltd. (hereinafter referred to as "Jiahong Dental") released its 2025 annual report. The report shows that the company achieved operating revenue of RMB 511 million in 2025, a slight decrease of 1.31% compared to RMB 518 million in 2024; net profit attributable to shareholders of the parent company was RMB 46.3972 million, down 11.26% year-on-year; net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was RMB 45.1263 million, down 12.38% year-on-year.

Source: Jiahong Dental 2025 Annual Report

By product segment, Jiahong Dental's core business, dental prosthesis products, maintained growth in 2025, achieving revenue of RMB 435 million, a year-on-year increase of 1.96%. However, implant products saw a decline in revenue due to market environment impacts, with full-year revenue of RMB 65.379 million, down 16.71% year-on-year. According to a previous report by DGN (Leading Dental Industry Media, DGN), the company's implant product revenue had already experienced a 20.04% year-on-year decline in the first half of 2025.

Source: Jiahong Dental 2025 Annual Report Source: Jiahong Dental 2025 Annual Report

In terms of regional performance, Jiahong Dental's overseas business outperformed its domestic market. Overseas revenue in 2025 reached RMB 273 million, up 2.36% year-on-year; while domestic revenue was RMB 228 million, down 4.62% year-on-year. The proportion of overseas market revenue rose to 54.48%, becoming the company's main source of income.

Notably, in May 2025, the U.S. imposed a 30% tariff on Chinese exports (with an additional 24% temporarily suspended for 90 days), and China imposed a 10% tariff on raw materials from the U.S. (with an additional 24% temporarily suspended for 90 days). To address the uncertainty of tariff fluctuations, Jiahong Dental established several new domestic and overseas subsidiaries during the reporting period, including SPARKDENT DIGITAL in Malaysia, as well as RAYGEN DENTAL, LAUREN TECH, CLOMED, KONZO, and BAIKON in Hong Kong and the U.S. The company stated that it aims to optimize its supply chain through overseas布局 and mitigate the direct impact of trade barriers.

Source: Jiahong Dental 2025 Annual Report

In terms of technology R&D, Jiahong Dental invested RMB 26.7867 million in R&D expenditures in 2025, accounting for 5.24% of operating revenue. During the reporting period, the company's R&D projects covered digital transformation, including full-arch edentulous digital chairside processing, AI denture design algorithms, and multi-layer gradient all-ceramic veneers, among other cutting-edge technologies. As of the end of the reporting period, the company held 131 patents, including 33 invention patents.

Source: Jiahong Dental 2025 Annual Report

Regarding profitability and cost control, the net cash flow from operating activities was RMB 55.1621 million, down 23.40% year-on-year. The decline in operating cash flow was mainly due to increased employee costs. During the reporting period, due to rising wages and social insurance contribution bases, employee compensation paid increased by RMB 17.52 million compared to the previous year.

The net cash flow from investing activities was RMB -10.2866 million, down 21.95% year-on-year. The decline in investing cash flow was primarily because the company acquired Shenzhen Gufu Precision Technology Co., Ltd. in 2024, with no such projects in 2025.

The net cash flow from financing activities was RMB -22.8491 million, down 69.73% year-on-year. The decline in financing cash flow was mainly due to the repayment of working capital loans and interest of RMB 70.1389 million in 2024, with no such projects in 2025, and the addition of shareholder dividends of RMB 15.4054 million in 2025.

As of the end of 2025, Jiahong Dental's total assets were RMB 661 million, up 2.35% from the end of the previous year. The company stated that in 2026, it will continue to increase R&D investment, enhance digital production capabilities, and leverage overseas subsidiaries to stabilize and expand its overseas market share.